Carotid Intima-Media Thickness Predicts the Development of Cardiovascular Events in Patients with Rheumatoid Arthritis

article

Carotid Intima-Media Thickness Predicts the Development of Cardiovascular Events in Patients with Rheumatoid Arthritis is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/J.SEMARTHRIT.2008.01.012
P698PubMed publication ID18336869

P50authorJavier MartinQ55089349
P2093author name stringCarlos Gonzalez-Juanatey
Javier Llorca
Miguel A. Gonzalez-Gay
P433issue5
P921main subjectcirculatory systemQ11068
patientQ181600
rheumatoid arthritisQ187255
P304page(s)366-371
P577publication date2009-04-01
P1433published inSeminars in Arthritis and RheumatismQ15761553
P1476titleCarotid Intima-Media Thickness Predicts the Development of Cardiovascular Events in Patients with Rheumatoid Arthritis
P478volume38

Reverse relations

cites work (P2860)
Q52684868A genetic association study of carotid intima-media thickness (CIMT) and plaque in Mexican Americans and European Americans with rheumatoid arthritis.
Q35907814Advanced glycation endproducts are increased in rheumatoid arthritis patients with controlled disease
Q50553806Amino-terminal pro-brain natriuretic peptide as a prognostic marker in patients with rheumatoid arthritis
Q34450615Analysis of the interferon gamma (rs2430561, +874T/A) functional gene variant in relation to the presence of cardiovascular events in rheumatoid arthritis
Q36151574Anti-TNF-alpha-adalimumab therapy is associated with persistent improvement of endothelial function without progression of carotid intima-media wall thickness in patients with rheumatoid arthritis refractory to conventional therapy
Q38857820Anti-citrullinated peptide antibodies and their value for predicting responses to biologic agents: a review
Q84089796Assessment of cardiovascular risk in rheumatoid arthritis: impact of the new EULAR recommendations on the score cardiovascular risk index
Q41670041Assessment of intracranial vessels in association with carotid atherosclerosis and brain vascular lesions in rheumatoid arthritis.
Q48548043Assessment of local carotid stiffness in seronegative and seropositive rheumatoid arthritis
Q35617635Association of acid phosphatase locus 1*C allele with the risk of cardiovascular events in rheumatoid arthritis patients
Q58743766Association of circulating calprotectin with lipid profile in axial spondyloarthritis
Q30396421Associations between Carotid Artery Plaque Score, Carotid Hemodynamics and Coronary Heart Disease
Q27010113Atherosclerosis in juvenile idiopathic arthritis
Q37786648Atherosclerotic vascular damage and rheumatoid arthritis: a complex but intriguing link
Q46635567Automated radiofrequency-based US measurement of common carotid intima-media thickness in RA patients treated with synthetic vs synthetic and biologic DMARDs.
Q38230867Beyond the joint: Subclinical atherosclerosis in rheumatoid arthritis
Q35864204Biomarkers of subclinical atherosclerosis in patients with autoimmune disorders
Q36490766CARD8 rs2043211 (p.C10X) polymorphism is not associated with disease susceptibility or cardiovascular events in Spanish rheumatoid arthritis patients
Q35617726CCR5Δ32 variant and cardiovascular disease in patients with rheumatoid arthritis: a cohort study
Q38185646Can suppression of inflammation by anti-TNF prevent progression of subclinical atherosclerosis in inflammatory arthritis?
Q38568465Cardiovascular comorbidity in rheumatic diseases
Q36218375Cardiovascular disease and rheumatoid arthritis: an update
Q38950371Cardiovascular disease in patients with rheumatoid arthritis
Q34495257Cardiovascular disease in rheumatoid arthritis: a systematic literature review in latin america
Q33766283Cardiovascular disease is increased prior to onset of rheumatoid arthritis but not osteoarthritis: the population-based Nord-Trøndelag health study (HUNT)
Q37859676Cardiovascular disease risk in rheumatoid arthritis: progress, debate, and opportunity
Q28082992Cardiovascular disease risk scores in the current practice: which to use in rheumatoid arthritis?
Q34081242Cardiovascular involvement in autoimmune diseases
Q26739070Cardiovascular risk assessment in patients with rheumatoid arthritis: The relevance of clinical, genetic and serological markers
Q38090373Cardiovascular risk in juvenile idiopathic arthritis
Q53101781Cardiovascular risk stratification in rheumatic diseases: carotid ultrasound is more sensitive than Coronary Artery Calcification Score to detect subclinical atherosclerosis in patients with rheumatoid arthritis.
Q37796382Carotid Intima Media Thickness in Rheumatoid Arthritis as Compared to Control Subjects: A Meta-Analysis
Q35222947Carotid artery plaque in women with rheumatoid arthritis and low estimated cardiovascular disease risk: a cross-sectional study
Q59794786Carotid artery volumetric measures associate with clinical ten-year cardiovascular (CV) risk scores and individual traditional CV risk factors in rheumatoid arthritis; a carotid-MRI feasibility study
Q35777047Carotid atherosclerosis predicts incident acute coronary syndromes in rheumatoid arthritis
Q40885947Carotid intima-media thickness and endothelial function: useful surrogate markers for establishing cardiovascular risk in patients with inflammatory rheumatic disease
Q45751847Carotid intima-media thickness and endothelial function: useful surrogate markers for establishing cardiovascular risk in patients with inflammatory rheumatic disease – authors' response.
Q37596934Carotid intima-media thickness measurement in cardiovascular screening programmes
Q37691111Classical cardiovascular disease risk factors associate with vascular function and morphology in rheumatoid arthritis: a six-year prospective study.
Q43581222Clinical significance of brachial flow-mediated dilation in patients with rheumatoid arthritis
Q89278102Comparison of statin eligibility according to the Adult Treatment Panel III, ACC/AHA blood cholesterol guideline, and presence of carotid plaque by ultrasound in Mexican mestizo patients with rheumatoid arthritis
Q37246482Coronary Artery Calcification Is Related to Inflammation in Rheumatoid Arthritis: A Long-Term Follow-Up Study
Q35557952Correlation between endothelial function and carotid atherosclerosis in rheumatoid arthritis patients with long-standing disease
Q51174739Could cardiovascular disease risk stratification and management in rheumatoid arthritis be enhanced?
Q41482717Differential Association of Psychosocial Comorbidities With Subclinical Atherosclerosis in Rheumatoid Arthritis
Q44973053Effects of rosuvastatin on subclinical atherosclerosis and arterial stiffness in rheumatoid arthritis: a randomized controlled pilot trial
Q87621947Epicardial adipose tissue thickness, flow-mediated dilatation of the brachial artery, and carotid intima-media thickness: Associations in rheumatoid arthritis patients
Q36165202Genetic markers of cardiovascular disease in rheumatoid arthritis.
Q91715328Identification of a 3'-Untranslated Genetic Variant of RARB Associated With Carotid Intima-Media Thickness in Rheumatoid Arthritis: A Genome-Wide Association Study
Q42326308Implication of new atherosclerotic carotid plaques in the cardiovascular outcome of patients with rheumatoid arthritis
Q90415124Important Considerations for Examining Endothelial Dysfunction in Rheumatoid Arthritis
Q92708651Incidence and effect of insulin resistance on progression of atherosclerosis in rheumatoid arthritis patients of long disease duration
Q37206972Inflammation predicts accelerated brachial arterial wall changes in patients with recent-onset rheumatoid arthritis.
Q42755997Inflammation, endothelial function and atherosclerosis in rheumatoid arthritis
Q44958376Inflammatory burden interacts with conventional cardiovascular risk factors for carotid plaque formation in rheumatoid arthritis
Q37563513Influence of coronary artery disease and subclinical atherosclerosis related polymorphisms on the risk of atherosclerosis in rheumatoid arthritis.
Q37184930Influence of elevated-CRP level-related polymorphisms in non-rheumatic Caucasians on the risk of subclinical atherosclerosis and cardiovascular disease in rheumatoid arthritis
Q34485757Interferon regulatory factor 5 genetic variants are associated with cardiovascular disease in patients with rheumatoid arthritis
Q36172927Is Lipoprotein-Associated Phospholipase A2 a Link between Inflammation and Subclinical Atherosclerosis in Rheumatoid Arthritis?
Q35217530Kidney function, endothelial activation and atherosclerosis in black and white Africans with rheumatoid arthritis
Q37699878Lack of association between ABO, PPAP2B, ADAMST7, PIK3CG, and EDNRA and carotid intima-media thickness, carotid plaques, and cardiovascular disease in patients with rheumatoid arthritis
Q36081372Lack of association between TLR4 rs4986790 polymorphism and risk of cardiovascular disease in patients with rheumatoid arthritis
Q57307072Lack of association of IL6R rs2228145 and IL6ST/gp130 rs2228044 gene polymorphisms with cardiovascular disease in patients with rheumatoid arthritis
Q35489690Longitudinal predictors of progression of carotid atherosclerosis in rheumatoid arthritis
Q26822038Metabolic syndrome in rheumatoid arthritis
Q36245756Obesity and carotid atherosclerosis in African black and Caucasian women with established rheumatoid arthritis: a cross-sectional study
Q34128912Osteoprotegerin CGA haplotype protection against cerebrovascular complications in anti-CCP negative patients with rheumatoid arthritis
Q36245670Predictors of new atherosclerotic carotid plaque development in patients with rheumatoid arthritis: a longitudinal study
Q58728255Prospective assessment of cardiovascular risk parameters in patients with rheumatoid arthritis
Q35842035Protective Role of the Interleukin 33 rs3939286 Gene Polymorphism in the Development of Subclinical Atherosclerosis in Rheumatoid Arthritis Patients.
Q45669904Relationship between inflammatory markers, oxidant-antioxidant status and intima-media thickness in prepubertal children with juvenile idiopathic arthritis
Q50881501Relationship between pulse wave velocity and serum YKL-40 level in patients with early rheumatoid arthritis.
Q36830486Rheumatoid arthritis impacts on the independent relationships between circulating adiponectin concentrations and cardiovascular metabolic risk
Q37691220Rheumatoid arthritis is associated with reduced adiposity but not with unfavorable major cardiovascular risk factor profiles and enhanced carotid atherosclerosis in black Africans from a developing population: a cross-sectional study
Q60592413Rheumatoid arthritis is sufficient to cause atheromatosis but not arterial stiffness or hypertrophy in the absence of classical cardiovascular risk factors
Q27008359Role of adipokines in atherosclerosis: interferences with cardiovascular complications in rheumatic diseases
Q42640261Role of carotid ultrasonography in the evaluation of cardiovascular risk in patients with rheumatoid arthritis
Q37691093SCORE and REGICOR function charts underestimate the cardiovascular risk in Spanish patients with rheumatoid arthritis
Q35035496SMAD3 rs17228212 gene polymorphism is associated with reduced risk to cerebrovascular accidents and subclinical atherosclerosis in anti-CCP negative Spanish rheumatoid arthritis patients.
Q37294162Serum Resistin Level and Progression of Atherosclerosis during Glucocorticoid Therapy for Systemic Autoimmune Diseases
Q34697924Serum amyloid A as a marker of persistent inflammation and an indicator of cardiovascular and renal involvement in patients with rheumatoid arthritis
Q35257568Significant effects of biologic therapy on lipid profiles and insulin resistance in patients with rheumatoid arthritis
Q43407682Single-nucleotide polymorphisms at the 9p21.3 genomic region not associated with the risk of cardiovascular disease in patients with rheumatoid arthritis
Q58767097Spectral Doppler and automated software-guided ultrasound assessment of bilateral common carotid intima-media thickness in spondyloarthritis: is there a correlation with clinical findings?
Q34482096Study of association of CD40-CD154 gene polymorphisms with disease susceptibility and cardiovascular risk in Spanish rheumatoid arthritis patients.
Q34590834Subclinical atherosclerosis in patients with rheumatoid arthritis by utilizing carotid intima-media thickness as a surrogate marker.
Q34550743Systemic inflammation and cardiovascular risk factors predict rapid progression of atherosclerosis in rheumatoid arthritis
Q38519523Targeting inflammation in the prevention of cardiovascular disease in patients with inflammatory arthritis.
Q46174533The 11q23.3 genomic region-rs964184-is associated with cardiovascular disease in patients with rheumatoid arthritis.
Q41211836The 2013 ACC/AHA 10-year atherosclerotic cardiovascular disease risk index is better than SCORE and QRisk II in rheumatoid arthritis: is it enough?
Q34388576The ZC3HC1 rs11556924 polymorphism is associated with increased carotid intima-media thickness in patients with rheumatoid arthritis
Q35204645The ability of the 2013 American College of Cardiology/American Heart Association cardiovascular risk score to identify rheumatoid arthritis patients with high coronary artery calcification scores
Q33938590The association between microvascular and macrovascular endothelial function in patients with rheumatoid arthritis: a cross-sectional study.
Q33584053The relationship between race, cigarette smoking and carotid intimal medial thickness in systemic lupus erythematosus
Q34272487The role of inflammation and cardiovascular disease risk on microvascular and macrovascular endothelial function in patients with rheumatoid arthritis: a cross-sectional and longitudinal study
Q37533298Towards improving cardiovascular risk management in patients with rheumatoid arthritis: the need for accurate risk assessment
Q46468090Tumour necrosis factor blocking agents and progression of subclinical atherosclerosis in patients with ankylosing spondylitis
Q34164481Validated methods for assessment of subclinical atherosclerosis in rheumatology
Q53827279Variables associated with subclinical atherosclerosis in a cohort of rheumatoid arthritis patients: Sex-specific associations and differential effects of disease activity and age.

main subject (P921)
Q64640827Cardiovascular Disease Biomarkers in Smokers and Moist Snuff Consumers
Q66393513Carotid Intima-media Thickness as Cardiovascular Mortality Predictor in Peritoneal Dialysis Patients
Q64806423Dapagliflozin, Cardio-Metabolic Risk Factors and Type-2 Diabetes
Q63818033Effect of NCX4016 on Walking Distance in Patients With Peripheral Arterial Occlusive Disease (PAOD)
Q64046848Effectiveness of Growth Hormone Releasing Hormone in Reducing Abdominal Fat in People Who Are Obese
Q65333041Efficacy and Safety of Simvastatin-ezetimibe Combination Therapy Among Patients With SLE
Q65347197High-Intensity Aerobic Interval Training in Testicular Cancer Survivors
Q64397455Low-dose Colchicine in Patients With Type 2 Diabetes Mellitus and Microalbuminuria
Q65538279Multiple Interventions Related to Dialysis Procedures in Order to Reduce Cardiovascular Morbidity and Mortality in HD Patients(EGESTUDY)
Q64818753Omega 3 Fatty Acids in Patients With Chronic Renal Disease
Q66407985Periodontal and Cardiovascular Diseases Project
Q63338904Polypill Effects on Sub Clinical Atherosclerosis (PESCA) Trial
Q65539922Predictor of Advanced Sub-Clinical Atherosclerosis (PASA) Study
Q62031277The "ABCDE" Score as a Five-step Vascular Ultrasound Examination in Heart Failure
Q65355899The Effect of Plant-based Diets (Vegetarian and Vegan) on Endothelial Function and Atherogenic Parameters
Q64608316The Effect of Puerarin Injection on Carotid Intima-Media Thickness in Patients With Rheumatoid Arthritis
Q65378116Trial of Lycopene/Ateronon for Secondary Prevention of Coronary Heart Disease

Search more.